Table 1.

Cascade of patients with chronic hepatitis B in care, receiving HBV tests and on antiviral therapy, 2010-2018

	Year
	2010	2011	2012	2013	2014	2015	2016	2017	2018
Estimated total number of HBsAg(+) persons	331,590	370,339	398,925	422,336	446,183	460,024	473,086	489,171	507,782
Estimated eligible CHB patients for treatment	124,579	139,136	149,876	158,672	167,631	172,831	177,738	183,782	190,774
No. of CHB patients in care	15,810	33,926	47,570	58,122	65,947	74,352	80,565	87,833	94,495
% per 100 estimated HBsAg(+) persons	4•77%	9•16%	11•92%	13•76%	14•78%	16•16%	17•03%	17•96%	18•61%
No. of CHB patients receiving HBV tests	14,629	29,821	41,876	51,018	57,113	63,850	68,472	76,156	83,240
% per 100 estimated HBsAg(+) persons	4•41%	8•05%	10•50%	12•08%	12•80%	13•88%	14•47%	15•57%	16•39%
No. of CHB patients receiving antiviral therapy	4,886	17,556	26,798	33,584	39,737	45,086	49,798	54,487	58,908
% per 100 estimated eligible CHB patients for treatment	3•92%	12•62%	17•88%	21•17%	23•71%	26•09%	28•02%	29•65%	30•88%
% per 100 CHB patients in care	30•90%	51•75%	56•33%	57•78%	60•26%	60•64%	61•81%	62•03%	62•34%
No. of CHB patients ever in care	-	40,128	65,229	90,630	115,507	141,026	165,836	191,475	216,667
% per 100 estimated HBsAg(+) persons	-	10•84%	16•35%	21•46%	25•89%	30•66%	35•05%	39•14%	42•67%
No. of CHB patients ever receiving HBV tests	-	36,284	59,764	83,584	106,718	130,407	153,450	177,714	201,681
% per 100 estimated HBsAg(+) persons	-	9•80%	14•98%	19•79%	23•92%	28•35%	32•44%	36•33%	39•72%
No. of CHB patients ever receiving antiviral therapy	-	18,492	30,163	41,131	52,085	62,967	73,467	84,063	94,390
% per 100 estimated eligible CHB patients for treatment	-	13•29%	20•13%	25•92%	31•07%	36•43%	41•33%	45•74%	49•48%
% per 100 CHB patients ever in care	-	46•08%	46•24%	45•38%	45•09%	44•65%	44•30%	43•90%	43•56%

CHB, chronic hepatitis B.